Literature DB >> 3758606

Clostridium difficile cytotoxin inhibits protein synthesis in fibroblasts and intestinal mucosa.

C Pothoulakis, G Triadafilopoulos, M Clark, C Franzblau, J T LaMont.   

Abstract

The pathophysiology of Clostridium difficile colitis is thought to be mediated by release of toxin A, an enterotoxin, and toxin B, a cytotoxin. We compared the differential effects of toxin B on protein synthesis in IMR-90 fibroblasts and in hamster esophagus, stomach, gallbladder, small intestine, and cecum in organ culture. Toxin B in low concentrations stimulated (p less than 0.001) incorporation of [3H]leucine into fibroblast proteins, whereas at higher dosages it inhibited incorporation (p less than 0.001). This biphasic effect was independent of cell rounding and was not caused by a change in uptake of precursor. Purified toxin B had no effect on protein synthesis in a cell-free rabbit reticulocyte translation system, indicating that inhibition of protein synthesis in intact fibroblast monolayers and intestinal explants is a consequence of toxin B effect on some other cellular target. Toxin B significantly inhibited protein synthesis in hamster cecal explants in a dose-dependent fashion. Again, this inhibition was not mediated by altered precursor uptake. Toxin B significantly inhibited in vitro protein synthesis in hamster terminal ileum, cecum, and sigmoid colon, but not in esophagus, gallbladder, stomach, or duodenum. These results suggest that toxin B-mediated inhibition of protein synthesis may be a generalized toxic effect in tissue culture cells and intestinal epithelium. Inhibition of protein synthesis in the distal intestinal epithelium may contribute to the pathophysiology of colitis caused by this organism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758606     DOI: 10.1016/s0016-5085(86)80010-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.

Authors:  I Castagliuolo; M F Riegler; L Valenick; J T LaMont; C Pothoulakis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 2.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity.

Authors:  Jin Ku Kang; Jae Sam Hwang; Hyo Jung Nam; Keun Jae Ahn; Heon Seok; Sung-Kuk Kim; Eun Young Yun; Charalabos Pothoulakis; John Thomas Lamont; Ho Kim
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

4.  CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

Authors:  C Pothoulakis; I Castagliuolo; J T LaMont; A Jaffer; J C O'Keane; R M Snider; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

Review 5.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

6.  Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.

Authors:  R Eglow; C Pothoulakis; S Itzkowitz; E J Israel; C J O'Keane; D Gong; N Gao; Y L Xu; W A Walker; J T LaMont
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Comparison of two commercially available enzyme immunoassays for detection of Clostridium difficile in stool specimens.

Authors:  S S Altaie; P Meyer; D Dryja
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

8.  Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.

Authors:  C Pothoulakis; J T LaMont; R Eglow; N Gao; J B Rubins; T C Theoharides; B F Dickey
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

9.  Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.

Authors:  M Riegler; R Sedivy; C Pothoulakis; G Hamilton; J Zacherl; G Bischof; E Cosentini; W Feil; R Schiessel; J T LaMont
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

10.  Clostridium difficile toxins A and B inhibit human immune response in vitro.

Authors:  W Däubener; E Leiser; C von Eichel-Streiber; U Hadding
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.